Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

<keyword id="20207838" type="General" weightage="20" keywordseo="dsp-mutual-fund" source="keywords">DSP Mutual Fund</keyword>'s September 2024 Netra report credits <keyword id="19895063" type="General" weightage="20" keywordseo="india" source="keywords">India</keyword>'s strong economic recovery to increased fiscal expenditure. The report, which tracks current economic trends and market insights through various charts, emphasizes the need for the private corporate sector and households to play a larger role in sustaining the ongoing growth momentum. Netra also pointed out an unsettling calm in the markets, with the Nifty 50 TRI index maintaining an impressive 53-month streak without a 5% decline and 13 years without a drop greater than 10%. Sahil Kapoor, Head of Products and Market Strategist, DSP Mutual Fund, said, "The calm in the markets, marked by an unnerving lack of volatility, is a double-edged sword. While it provides a sense of stability, it also masks underlying risks that could surface unexpectedly, catching investors off guard. To ensure a sustainable recovery, there is a need for the private sector and households to take the lead, transforming fiscal stimulus into lasting economic growth." However, the report notes a shift in market dynamics, with the momentum factor, which has outperformed since the COVID-19 bottom, beginning to lose its dominance. At the same time, the quality factor, which had underperformed over the last four years, is now seeing a resurgence, potentially indicating a change in market leadership that could favour quality-orientated funds, both active and passive. The report highlights the critical role government spending has played in the recovery, with a focus on capital investments crucial for future growth. However, contributions from the private corporate sector and households have lagged. It also draws attention to a slowdown in India's per capita consumption, approaching lows seen in previous cycles. Given that consumption accounts for around 60% of GDP, it is vital that this sector grows at a rate exceeding GDP growth to stimulate private capital expenditure. India's <keyword id="487578" type="General" weightage="20" keywordseo="tax-collections" source="Orion">tax collections</keyword> have demonstrated robust growth, with gross tax revenue showing a five-year compound annual growth rate (CAGR) of 14 %. This growth, largely driven by <keyword id="6354751" type="General" weightage="20" keywordseo="income-tax" source="Orion">income tax</keyword>, indicates a rising dependency on capital gains and stock market performance, introducing new vulnerabilities to the economy. The banking and financial services sector (<keyword id="19910880" type="General" weightage="20" keywordseo="bfsi" source="keywords">BFSI</keyword>) has emerged as a key driver of market earnings, recording a 12 % increase in profit after tax (PAT) growth, significantly outpacing the 4.6 % growth observed in non-BFSI Nifty 50 companies. This disparity underscores the sector's importance in India's economic story and highlights promising investment opportunities.

India's strong economic recovery is led by fiscal expenditure: DSP MF

A recent <a href="https://academic.oup.com/mnrasl/article/535/1/L18/7760380">study</a> has revealed an unexpected consequence of the global lockdowns imposed in 2020 to curb the spread of COVID-19: a measurable cooling of the <keyword id="19899207" type="General" weightage="20" keywordseo="moon" source="keywords">Moon</keyword>'s surface. Indian researchers from the <keyword id="20178202" type="General" weightage="20" keywordseo="Physical-Research-Laboratory" source="keywords" meta.keywordsubtype="org" meta.entityname="Physical Research Laboratory" meta.hostid="261" meta.entityid="Physical Research Laboratory">Physical Research Laboratory</keyword> (PRL) analysed night-time temperatures at six different locations on the Moon's near side between 2017 and 2023. Using data from NASA's Lunar Reconnaissance Orbiter, they discovered a consistent temperature drop of 8-10 Kelvin during the strictest lockdown period of April-May 2020 compared to previous years. For instance, the coldest temperature was recorded in 2020, with a value of 96.2 K at one location. In contrast, post-lockdown years like 2021 and 2022 saw a gradual warming trend as human activity resumed. <div type="Article" hostid="261" msid="111772552" title="Newly discovered Moon caves could shelter astronauts as they set up lunar bases!" mstype="2" mssubtype="0"></div>The researchers posit that this unusual cooling can be attributed to a reduction in Earth's outgoing radiation during the lockdowns. As human activity slowed down, <keyword id="20107362" type="General" weightage="20" keywordseo="greenhouse-gas-emissions" source="keywords">greenhouse gas emissions</keyword> and aerosols decreased significantly. This meant less heat was trapped and re-emitted by Earth's atmosphere, resulting in a measurable decrease in the radiation reaching the Moon. Further, the Moon's surface acts as an amplifier of Earth's radiation signature. And this unique global event provided a rare opportunity to observe how changes in human activity on Earth can affect our nearest celestial neighbour. While the study presents a compelling correlation, the authors acknowledge that more data is needed to definitively establish the link between Earth's radiation changes and <keyword id="23366659" type="General" weightage="100" keywordseo="lunar-surface-temperatures" source="keywords">lunar surface temperatures</keyword>. They suggest that future Moon-based observatories could play a crucial role in studying Earth's climate and environmental shifts. <div type="Article" hostid="261" msid="112222991" title="Scientists want to send our endangered species to the Moon to “save” them" mstype="2" mssubtype="0"></div>This unexpected finding highlights the interconnectedness of our solar system and the far-reaching impacts of human activities on our planet. As we continue to grapple with the challenges of <keyword id="19907392" type="General" weightage="20" keywordseo="climate-change" source="keywords">climate change</keyword>, understanding these subtle interactions between Earth and the Moon can provide valuable insights into our planet's complex systems. (With inputs from TOI)

The Covid lockdowns did WHAT to the Moon?!

As many as 290 cases of <keyword id="21545939" type="General" weightage="20" keywordseo="KP-2" source="keywords">KP.2</keyword> and 34 cases of <keyword id="21748081" type="General" weightage="20" keywordseo="KP-1" source="keywords">KP.1</keyword>, both sub-lineages of COVID-19 that are responsible for surge in cases in Singapore, have been found in India, according to official data. However, a source in the Union health ministry told PTI that they are all sub variants of <keyword id="20115417" type="General" weightage="20" keywordseo="JN1" source="keywords">JN1</keyword> and there is no associated increase in hospitalisation and severe cases. "So there is no reason for concern or panic. The mutations will keep happening at a rapid pace and this is the natural behaviour of viruses like SARS-CoV2," the source said. The source further said that the INSACOG surveillance is sensitive and is able to pick up the emergence of any new variant and samples are also picked from hospitals in a structured manner to detect any change in the severity of disease due to virus. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed that 34 cases of KP.1 have been found across seven states and UTs with 23 cases registered from West Bengal. The other states are Goa (1), Gujarat (2), Haryana (1), Maharashtra (4) Rajasthan (2) and Uttarakhand (1). As many as 290 cases of KP.2 have been registered with Maharashtra reporting the highest number at 148, according to the data. The other states and Union territories are Delhi (1), Goa (12), Gujarat (23), Haryana (3), Karnataka (4), Madhya Pradesh (1), Odisha (17), Rajasthan (21), Uttar Pradesh (8), Uttarakhand (16) and West Bengal (36). Singapore is seeing a new COVID-19 wave as the authorities recorded more than 25,900 cases from May 5 to 11 with KP.1 and KP.2 accounting for over two-thirds of cases in Singapore. Globally, the predominant COVID-19 variants are still JN.1 and its sub-lineages, including KP.1 and KP.2. KP.1 and KP.2 belong to a group of COVID-19 variants scientists have nicknamed 'FLiRT', after the technical names of their mutations. The strains in FLiRT are all descendants of the JN.1 variant, an offshoot of the Omicron variant. KP.2 was classified by the World Health Organization as a Variant Under Monitoring.

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

Ever since the virus reared its ugly head and briefly sent the world into despair, the coronavirus has remained a staple, albeit almost sidelined, part of the news cycle. Despite this, the topic has come to the forefront of controversy once again, with an extremely popular <keyword id="20040659" type="General" weightage="20" keywordseo="COVID-19-vaccine" source="keywords">COVID-19 vaccine</keyword> now under scrutiny. Considering that the world is still healing from the scars left behind by the coronavirus tragedy, it is imperative that we gauge the situation to avoid any unwarranted public paranoia. Let’s look at the facts behind the ongoing <keyword id="19910149" type="General" weightage="20" keywordseo="AstraZeneca" source="keywords" meta.keywordsubtype="org" meta.entityname="AstraZeneca" meta.hostid="261" meta.entityid="AstraZeneca">AstraZeneca</keyword> (or <keyword id="19960109" type="General" weightage="100" keywordseo="covishield" source="keywords">Covishield</keyword>, as it is known in India) vaccine controversy, and determine if there really is a cause for worry. <cmsannotation type="cmsannotation" annotationid="What happened?" comment="subhead" text="What happened?">What happened?</cmsannotation> Shortly after receiving the AstraZeneca COVID-19 vaccine in 2021, UK-based <keyword id="21472612" type="General" weightage="20" keywordseo="jamie-scott" source="keywords">Jamie Scott</keyword> experienced a harrowing ordeal. He developed a brain clot and severe bleeding, resulting in permanent brain injury. This condition, known as <keyword id="21475609" type="General" weightage="20" keywordseo="Thrombosis-with-Thrombocytopenia-Syndrome" source="keywords">Thrombosis with Thrombocytopenia Syndrome</keyword> (<keyword id="20218859" type="General" weightage="20" keywordseo="tts" source="keywords">TTS</keyword>), can lead to dangerously low blood clot and platelet levels, posing a grave risk to those affected. Jamie's struggles with memory loss, impaired vision, and diminished cognitive abilities compelled him to seek legal recourse against the pharmaceutical company in 2023. Jamie's legal representative contends that AstraZeneca minimized the potential risks linked to their vaccines. Moreover, reports indicate that over 50 vaccinated individuals experienced similar adverse conditions, with numerous cases resulting in fatalities or severe injuries. Despite these assertions, the pharmaceutical company refutes the allegations, stating that they do not acknowledge a causal relationship between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS) on a generic level. However, a year of court wrangling later, legal documents submitted by AstraZeneca have now admitted that their vaccine can cause TTS in very rare cases, although the causal mechanism is still not well known. This revelation has led to renewed uproar against the vaccine’s side-effects. <cmsannotation type="cmsannotation" annotationid="Is there cause for worry?" comment="subhead" text="Is there cause for worry?">Is there cause for worry?</cmsannotation> In short words, not really. Links between the <keyword id="21483117" type="General" weightage="20" keywordseo="AstraZeneca-vaccine" source="keywords">AstraZeneca vaccine</keyword> and vaccine-induced immune TTS have been scientifically identified since early 2021, soon after the first COVID-19 vaccines had come out. However, it is so very rare — a few dozen reported cases among the millions administered — that even the World Health Organisation has deemed the vaccine “safe and effective” for all individuals aged 18 and above. Moreover, even influenza, H1N1 and rabies vaccines can cause TTS in very rare instances. Further, it is important to note that an infection with COVID-19 is itself a major cause for clot, heart attacks and strokes. Being vaccinated actually lowers these risks. There is also the fact that all vaccines or drugs carry potential side-effects, and these medical interventions are only cleared for release after determining that their benefits vastly outweigh any complications. Finally, the <keyword id="21483118" type="General" weightage="20" keywordseo="TTS-side-effects" source="keywords">TTS side-effects</keyword> — which include symptoms such as headaches, blurred vision, chest pain, leg swelling or tiny blood spots under the skin — manifest between 1-6 weeks of vaccination. Considering that most Indians received their Covishield jab a couple of years ago, there should be no reason to panic now. <cmsannotation type="cmsannotation" annotationid="Is it time to consider alternate vaccines?" comment="subhead" text="Is it time to consider alternate vaccines?">Is it time to consider alternate vaccines?</cmsannotation> There is no particular hard evidence that suggests the supremacy of one vaccine over another, considering that they all carry varying degrees of side-effects. That being said, <keyword id="9485939" type="General" weightage="20" keywordseo="covaxin" source="Orion">Covaxin</keyword> boasts a higher efficacy than Covishield, and has better research data among Indian subjects. However, it may also be important to know that the administration of the AstraZeneca vaccine has been discontinued in many countries, mainly due the aforementioned risk of blood clotting in certain age groups. Whatever the choice, the fact of the matter remains that these vaccines have saved millions since their introduction, and it is pertinent that we continue taking them diligently, unless any premier health authorities recommend otherwise.

Should you be worried about the potential side-effects of the Covishield vaccine?

The Indian Council of Medical Research Director General Dr Rajiv Bahl on Monday criticised a recently published study on the long-term safety analysis of the <keyword id="9485939" type="General" weightage="100" keywordseo="covaxin" source="Orion">Covaxin</keyword> in adults and adolescents for its poor methodology and design, and clarified the article misleadingly and erroneously "acknowledges" <keyword id="19918794" type="General" weightage="20" keywordseo="ICMR" source="keywords">ICMR</keyword>. Dr Bahl said the study had no control arm of unvaccinated individuals for comparing the rates of events between the vaccinated and unvaccinated groups. Hence, the reported events in the study cannot be linked or attributed to COVID-19 vaccination. He added that the ICMR is not associated with the study and has not provided any financial or technical support for the research. The ICMR DG has written a letter to the authors of the paper and Editor of the journal to immediately remove the acknowledgement to ICMR and publish an erratum. A research paper, titled 'Long-Term Safety Analysis of the BBVl52 <keyword id="21730391" type="General" weightage="20" keywordseo="coronavirus-vaccine" source="keywords">Coronavirus Vaccine</keyword> in Adolescents and Adults: Findings from a l-Year Prospective Study in North India' stated that nearly one-third of the 926 participants in the study who received Bharat Biotech's anti-Covid vaccine Covaxin reported 'adverse events of special interest,' or AESI. Dr Bahl said that ICMR was acknowledged for research support without any prior approval of or intimation to ICMR, which is inappropriate and unacceptable. He stated that ICMR cannot be associated with this poorly designed study which purports to present a "safety analysis" of Covaxin due to several critical flaws. He said the study does not even provide background rates of observed events in the population, making it impossible to assess the change in incidence of observed events in the post-vaccination period. Baseline information of study participants is missing. The study tool used is inconsistent with 'Adverse Events of Special Interest (AESI)' as defined in the reference provided in the paper for AESI. The method of data collection has a high risk of bias, he said. Study participants were contacted telephonically one year after vaccination and their responses were recorded without any confirmation with clinical records or by physician examination, he pointed out. Dr Bahl also noted that similar acknowledgements to ICMR have been made in previous papers without permission, raising concerns about the authors' practices. "The authors have been urged to immediately rectify the acknowledgment to ICMR and publish an erratum. Additionally, they are asked to address the methodological concerns raised. Failure to do so may prompt ICMR to consider legal and administrative action," he said. The Editor has been asked to retract the paper which implicitly makes conclusions on <keyword id="21495684" type="General" weightage="20" keywordseo="vaccine-safety" source="keywords">vaccine safety</keyword> which are not supported by evidence. The study, conducted by researchers from the Banaras Hindu University from January 2022 to August 2023, stated that nearly 50 per cent of 926 study participants in the study complained of infections during the follow-up period, predominated by viral upper respiratory tract infections. Serious AESI, which included stroke and Guillain-Barre syndrome, were reported in one per cent of individuals, the study, which looked at long-term safety of the BBV152 (Covaxin) vaccine in adolescents and adults, claimed. The study involved 635 adolescents and 291 adults, who received the BBV152 vaccine.

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

During the coronavirus pandemic, offices around the world had to alter their way of working and make work from home the norm to keep people safe. For two years, almost all companies in the world offered <keyword id="20665553" type="General" weightage="20" keywordseo="remote-work" source="keywords">remote work</keyword> and there were reports that this would become the future of working. Employees enjoyed the new flexibility and realised how remote work can help them balance work and life with ease. However, contrary to what was perceived, companies began calling employees <keyword id="9081434" type="General" weightage="100" keywordseo="back-to-office" source="Orion">back to office</keyword> as soon as it was safe. <h2><keyword id="20122085" type="General" weightage="20" keywordseo="CEOs" source="keywords">CEOs</keyword> want employees back in offices </h2> In the last few months, there have been ample studies that show how employees are more productive while working from home or in a hybrid setup where they are required to come to office for 2-3 days in a week. Yet, companies are adamant on calling their employees back to offices. For instance, Amazon recently ordered its employees to return to office for five days a week, putting an end to remote work forever. Now, a new study by <keyword id="19896405" type="General" weightage="20" keywordseo="KPMG" source="keywords" meta.keywordsubtype="org" meta.entityname="KPMG" meta.hostid="261" meta.entityid="KPMG">KPMG</keyword> has revealed that majority of Indian CEOs are ready to incentivise employees who work from the office, marking a shift towards a more traditional work model post-pandemic. According to the KPMG 2024 India CEO Outlook, 91 percent of Indian CEOs are considering linking rewards, such as promotions and pay raises, to <keyword id="21386806" type="General" weightage="20" keywordseo="office-attendance" source="keywords">office attendance</keyword>. This figure is slightly higher than the global average of 87 percent, indicating a stronger push in India to encourage in-person work. The report, based on responses from 125 Indian CEOs, highlights a growing belief that office-based work fosters better collaboration, innovation, and productivity. As many as 78% of Indian CEOs expect their entire workforce to return to the office within the next three years, a trend mirrored globally, though at a slightly higher rate of 83%. <keyword id="20142903" type="General" weightage="20" keywordseo="Indian-companies" source="keywords">Indian companies</keyword> are increasingly focused on improving their employee value proposition—the set of benefits and incentives offered to employees. CEOs are prioritising a supportive and engaging office environment as key to attracting and retaining top talent. By linking rewards to in-office work, companies aim to align employee satisfaction with long-term growth objectives. <h2>Understanding what employees want </h2> Sunit Sinha, Partner and Head of Human Capital Advisory Solutions at KPMG in India, pointed out that in the post-COVID-19 era, it is crucial for businesses to understand the evolving preferences of employees. As workers reconsider their options, businesses need to adapt to remain competitive in the talent market. Sinha said that companies must use data to address employee needs, saying, “The power to shape the future of talent lies in staying informed and adapting proactively.” In addition to in-office incentives, the KPMG report also talked about the increasing role of technology, particularly generative AI, in workforce development. Half of the CEOs surveyed are prioritising the enhancement of workforce skills alongside their investment in AI. Indian CEOs believe generative AI can help develop diverse skills and prepare their teams for a future where technology plays a central role in operations. However, while CEOs are optimistic about the potential of AI, they also expressed concern over the lack of regulations governing the technology. Seventy-seven percent of Indian CEOs are apprehensive about the pace of AI regulation, higher than the global average of 69%. Despite these concerns, Indian business leaders remain confident in AI’s ability to enhance organisational performance and secure a competitive edge.

91 percent Indian CEOs want to reward employees who work from offices, majority expect to end remote work in three years

Union <keyword id="6356374" type="General" weightage="20" keywordseo="health-minister" source="Orion">Health Minister</keyword> Mansukh Mandaviya is scheduled to hold a virtual meeting with the Indian Medical Association (IMA) on Monday. The IMA informed that Mandaviya will hold the meeting via video conferencing at 4 pm regarding the <keyword id="15884888" type="General" weightage="20" keywordseo="covid-19-situation-and-preparedness" source="Orion">Covid-19 situation and preparedness</keyword>. On Saturday, Mandaviya said that the government has been working to control the <keyword id="8913021" type="General" weightage="20" keywordseo="spread-of-covid-19" source="Orion">spread of Covid-19</keyword> and urged the people to wear masks and follow covid appropriate behaviour. "We are working on alert mode to control the spread of Covid-19 and are conducting environmental, sewage and human surveillance. Virus RNA was found in the sewage samples in Delhi and Mumbai," Mandaviya had said. He further urged the people to wear masks, avoid crowded places and follow Covid-appropriate behaviour. The Union Ministry of Health and Family Welfare on Saturday decided to hold mock drills at all health facilities across the country on December 27 in the wake of the COVID alarm due to a surge in infection in many countries. This is to ensure readiness in the availability of oxygen support, and ICU beds among other preparedness measures in case of a surge of COVID cases in India. According to the Ministry, the objective of the exercise is to ensure the operational readiness of these health facilities for the management of COVID. Detailing the focus on the parameters during the mock drills, it said that the main focus will be on the bed capacities including isolation, oxygen-supported and ICU beds at the health facilities. Prime Minister Narendra Modi also chaired a high-level meeting on Thursday (December 22) to assess the COVID-19 situation in the country and cautioned against complacency while laying stress on testing and strengthening the surveillance measures, especially at international airports. He emphasized COVID-appropriate behavior at all times, especially in view of the upcoming festive season, including wearing masks in crowded public places. Union Home Minister Amit Shah, Union Health Miniter Mansukh Mandaviya and NITI Aayog Chief Executive Officer Parameswaran Iyer were among others who participated in the meeting. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/science/environment/news/bsip-study-mangroves-shrinking-in-india-due-to-climate-change/articleshow/96511070.cms">BSIP Study: Mangroves shrinking in India due to climate change</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/pm-modi-tells-people-to-be-vigilant-as-covid-cases-were-rising-in-many-countries/articleshow/96493073.cms">PM Modi tells people to be vigilant as Covid cases were rising in many countries</a>

Health Minister Mansukh Mandaviya to hold meeting with Indian Medical Association today

Are you one of the many who trade the hectic weekday grind for weekend relaxation, only to be met with a throbbing <keyword id="19957279" type="General" weightage="20" keywordseo="headache" source="keywords">headache</keyword>? The dreaded “weekend headache” or “weekend migraine” are often triggered by changes in routine and <keyword id="19983121" type="General" weightage="20" keywordseo="stress" source="keywords">stress</keyword> levels between weekdays and weekends — when the pressure valve finally releases, resulting in the so-called let-down effect. <h2>Why weekends hit back</h2>The primary trigger for a let-down or <keyword id="22663679" type="General" weightage="20" keywordseo="weekend-migraine" source="keywords">weekend migraine</keyword> is a sudden decrease in stress levels. This might sound counterintuitive, but your body reacts to the drastic shift from high tension to relaxation. During stressful periods, your body releases cortisol, a hormone that helps manage stress and reduce pain. But when the weekend arrives and the pace slows down, <keyword id="3733104" type="General" weightage="20" keywordseo="cortisol-levels" source="Orion">cortisol levels</keyword> dip, leaving our heads vulnerable to the <keyword id="20080248" type="General" weightage="20" keywordseo="migraine" source="keywords">migraine</keyword> attack. Other common triggers include: Anxiety: High anxiety levels can increase the risk of frequent headache episodes. Changes in sleep patterns: Both lack of sleep and excessive sleep can trigger headaches. Dietary factors: Consuming inflammatory seed oils like vegetable or canola oil can increase omega-6 levels, raising migraine risk. Low protein and omega-3 fat intake, as well as high carbohydrate and sugar consumption, are also linked to increased migraine episodes. Caffeine withdrawal can also trigger a let-down migraine. Specific foods: Foods rich in tyramine (e.g., cheese, kimchi, lemon, tofu, pickled beets), beta-phenylethylamine (e.g., chocolates, cocoa beans, eggs, natto, beans, herbs), and nitrates (e.g., leafy greens, processed meats) have been linked to migraines. <h2>India as the headache hotspot</h2>A <a href="https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-023-01619-9" data-type="tilCustomLink">study</a> on global migraine incidence overview trends from 1990 to 2019 revealed that India had the highest number of headache instances recorded in adults between the ages of 22 and 45 worldwide. Sadly, the pandemic, which came in 2020, likely only worsened the situation. According to the <a href="https://www.bayer.in/en/news/indians-report-rise-in-stress-levels-post-pandemic-new-saridon-headache-report" data-type="tilCustomLink" target="_blank">Saridon Headache Report</a> from 2023, the COVID-19 pandemic has significantly impacted stress levels. The report indicates that 1 in 3 people felt their stress levels increased post-pandemic, with 93% of individuals recognizing that increased stress levels affect the frequency and severity of their headaches. In fact, Mumbai emerged as the headache capital, with over 90% of residents reporting headaches. While not restricted to just the weekends, some research suggests that children are also increasingly suffering from similar headaches. In 2019, researchers reported that about 58.4% of school-going children are the victims of migraine, tension-type headaches, chronic daily headache, <keyword id="22663681" type="General" weightage="20" keywordseo="cluster-headache" source="keywords">cluster headache</keyword>, etc. <h2>When to seek help</h2>Popping a pill is usually our quick-fix for such headaches. And while occasional weekend migraines might be manageable, and not entirely worth a trip to the doctor’s, it is essential to watch for warning signs. Consult your primary healthcare provider if: <ul><li>Your migraines become more frequent or severe.</li><li>Over-the-counter pain relievers lose their effectiveness.</li><li>You experience new or unusual symptoms.</li></ul>Remember, understanding your triggers and making lifestyle adjustments can significantly reduce the frequency and severity of weekend migraines. With proper management, you can reclaim your weekends and enjoy the relaxation you deserve. <div type="Article" hostid="261" msid="108617638" title="Headaches, acidity, eyesight issues &amp;amp; more — working for over 52 hrs/wk is taking its toll on Indian techies" mstype="2" mssubtype="0"></div>

Weekend headaches plague many Indians, but how seriously should you take them?

<ul><li><keyword id="20940216" type="General" weightage="20" keywordseo="Synology" source="keywords" meta.keywordsubtype="org" meta.entityname="Synology" meta.hostid="261" meta.entityid="Synology">Synology</keyword> launched several new products at the Synology Solution Exhibition 2024.</li><li>The company has registered double-digit growth in India in the last three years.</li><li>We speak to the company’s <keyword id="22416016" type="General" weightage="20" keywordseo="joanne-weng" source="keywords">Joanne Weng</keyword> to learn more about the company and its plans in India.</li></ul> Taiwanese <keyword id="20653112" type="General" weightage="20" keywordseo="storage-solutions" source="keywords">storage solutions</keyword> provider Synology<a href="https://www.businessinsider.in/tech/news/synology-introduces-new-products-aimed-at-data-protection-and-scalability/articleshow/110711086.cms"> introduced</a> several new products aimed at offering <keyword id="20285436" type="General" weightage="20" keywordseo="data-management" source="keywords">data management</keyword> and protection needs of business organisations at the Synology Solution Exhibition 2024 held in Taiwan. The company announced products such as ActiveProtect, the new GS Series and surveillance solutions at the event. The company also offers Network-attached storage (NAS) devices. Business Insider India spoke with Joanne Weng, Director of International Business, Synology during the event about the company’s operations in India and its future plans. To start, can you tell us about Synology's mission and its recent focus on the Indian market? Synology's mission has always been to simplify IT management, making it accessible for everyone from tech-savvy users to those with minimal technical expertise. Recently, we've been focusing on expanding our presence in India, recognising the country's immense potential as a key market for our solutions. Can you share some insights into Synology's performance in India? Our performance in India has been impressive, with consistent double-digit growth over the past three years. The Indian market is among the top five for Synology in the Asia-Pacific region, reflecting the growing demand for reliable and scalable data storage solutions. Despite the challenges posed by the COVID-19 pandemic, the demand for our products has remained strong, highlighting their relevance in supporting business continuity. How has Synology built its local presence and support in India? We recognise the importance of being present in the market. We've invested in building a dedicated team to look after the Indian market, working closely with local partners to provide on-ground support and consultation. Our strategy of selling through channels ensures that customers can get the help they need from partners familiar with their specific requirements. How does Synology ensure ease of management for its users? Our solutions are designed for easy setup and management, ensuring minimal hassle for users. We focus on user-friendly interfaces and pre-configured settings, making our products accessible for small and medium-sized businesses (SMBs) as well as large enterprises. This approach helps streamline IT management, allowing users to focus on their core business activities. What steps does Synology take to set itself apart in terms of flexibility and scalability? One of our core strengths is the flexibility and scalability of our solutions. As businesses grow, their data storage needs evolve, and Synology offers scalable solutions that can adapt to these increasing demands. This makes us an ideal choice for enterprises experiencing rapid growth, especially with emerging technologies like AI that require robust data management capabilities. Security is a major concern for businesses today. How does Synology address this? Security is a top priority for us. Our solutions come with end-to-end encryption and other advanced security features to protect data. We have a dedicated PSIRT Team that collaborates with global security organisations and ethical hackers to ensure our products remain secure against evolving threats. Additionally, to strengthen our backup solutions, the upcoming ActiveProtect appliances will include features like air-gapping and isolating backup copies in a secure environment to protect against ransomware attacks. How does Synology maintain a customer-centric approach? Customer feedback is extremely valuable to us and drives our continuous improvement efforts. We work with organizations like Gartner for peer reviews to ensure we are meeting customer expectations and delivering high satisfaction levels. This customer-centric approach is a cornerstone of our strategy, ensuring that our products and services evolve in line with user needs. What can we expect from Synology in the future, especially in the Indian market? Looking ahead, we plan to continue focusing on the Indian market, leveraging our robust product portfolio to meet the growing demands of enterprises. Our upcoming products are set to offer even greater scalability and performance, catering to businesses with extensive data management needs. We're excited about the future and are committed to supporting the evolving needs of businesses in India. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/news/the-biggest-ipos-in-indias-history-lic-to-paytm-companies-that-have-raised-the-most-funds/articleshow/111690863.cms">The biggest IPOs in India’s history – LIC to Paytm, companies that have raised the most funds</a> <a href="https://www.businessinsider.in/business/auto/news/its-raining-discounts-maruti-suzuki-hyundai-tata-motors-and-others-offer-discounts-on-cars-as-sales-slowdown/articleshow/111688501.cms">It’s raining discounts – Maruti Suzuki, Hyundai, Tata Motors and others offer discounts on cars as sales slowdown</a> <a href="https://www.businessinsider.in/business/telecom/news/jio-vs-airtel-vs-vi-prepaid-plans-comparison-plan-benefits-and-price-comparison-after-tariff-hike/articleshow/111512587.cms">Jio vs Airtel vs Vi recharge plans comparison – plan benefits and price comparison after tariff hike</a>

You Searched For "covid 19 indians" and got 9 results

India's strong economic recovery is led by fiscal expenditure: DSP MF

ANI

The Covid lockdowns did WHAT to the Moon?!

Ashmita Gupta

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

PTI

Should you be worried about the potential side-effects of the Covishield vaccine?

Ankush Banerjee

BHU study on Covaxin side effects poorly designed, critically flawed: ICMR Director General

PTI

91 percent Indian CEOs want to reward employees who work from offices, majority expect to end remote work in three years

Divyanshi Sharma

Health Minister Mansukh Mandaviya to hold meeting with Indian Medical Association today

ANI

Weekend headaches plague many Indians, but how seriously should you take them?

Ashmita Gupta

Synology bets big on the Indian market amid strong growth, growing demand

Sourabh Jain

Popular Keywords

Buying Guides